Fig. 4From: Strain engraftment competition and functional augmentation in a multi-donor fecal microbiota transplantation trial for obesityInter-individual variability in donor strain engraftment. a Proportion of donor-engrafted strains in recipients at each post-treatment timepoint. Data points represent recipient fecal metagenome samples. b Engraftment efficiency of donors represents the proportion of strains within the donor’s fecal metagenome that engrafted among FMT recipients, detected at week 6. c Donor-specific contributions to overall strain engraftment in FMT recipientsBack to article page